If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Acquisition

18 Jul 2023 07:00

RNS Number : 2908G
Kingspan Group PLC
17 July 2023
 

 

Kingspan Group plc

 

Acquisition

 

Inside Information

 

17 July 2023

 

Kingspan Group plc ("Kingspan") announces the acquisition of a majority stake in Steico SE

 

Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, is pleased to announce that it has entered into an agreement with Schramek GmbH ("Schramek") to acquire c.51% of the shares of Steico SE ("Steico"), with an option to acquire a further c.10% of shares in Steico in the future.

 

Steico is the world leader in natural insulation and wood-based building envelope products, based in Germany and listed on the unofficial markets of several German Stock Exchanges. It has a very well invested asset base, with four large production sites comprising 27 lines situated in Poland and France, including additional capacity nearing completion with up to EUR200m revenue headroom.

 

Steico had audited operating revenues of EUR445m in the 12 months to 31 December 2022 and EBITDA of EUR90m in the same period. As at June 2023, Steico guided 2023 revenues of c.EUR378m at an EBIT margin of 8% - 10% (FY22 14.6%). As at 31 December 2022, Steico had gross assets of EUR509m.

 

The initial consideration for the shares will be EUR35 per share, plus potential deferred consideration of up to a further EUR35 per share contingent on achievement of specified thresholds with a material uplift in profitability. The initial consideration of approximately EUR251.4m will be satisfied on completion, with 25% of the consideration potentially being exchanged for new shares in Kingspan (subject to Kingspan share price at completion). The consideration payable under the put and call option to acquire Schramek's remaining c. 10% in Steico is for a capped amount based on a multiple of future earnings.

The acquisition is expected to be earnings neutral initially, based on Kingspan consensus EPS for 2023 and Steico guidance for 2023.

 

In addition to Steico's existing ambitious growth plans we anticipate significant long term leverage via the Kingspan sales channels. The existing Steico executive management team will be retained in the business, and will continue to manage and develop the business. Upon closing, Kingspan will seek fair representation on Steico's administrative board.

 

The acquisition is conditional on regulatory clearance, and is expected to complete in early 2024. Following completion, Steico will continue to maintain its listings on the German Stock Exchanges.

 

 

Gene Murtagh, Kingspan Chief Executive Officer, commented:

 

"The acquisition of a majority stake in Steico represents an exciting next step in our strategy to provide the full spectrum of insulation products. Its suite of wood-based building envelope solutions broadens our ability to enable our customers to meet their sustainability and energy performance needs. Kingspan's global routes to market, paired with our drive to innovate and widen the applications of Steico's current technologies, are key to our plans to bring Steico bio-based solutions to the next level."

 

Udo Schramek, Steico Chief Executive Officer, stated:

 

"It has been a great honour to lead the team at Steico to become the pre-eminent global supplier of wood-based insulation. We are now entering the next phase of growth and are very enthusiastic about the collaboration opportunities Kingspan brings, in both the existing Steico range and across the Kingspan portfolio and geographies. I am excited about the future for Steico and about being invested in the future growth of both companies."

 

 

Kingspan will hold an investor call at 8.30am IST on Tuesday 18 July 2023 to discuss the acquisition.

 

Operator Assisted Dial-In: United Kingdom (Local): +44 20 4587 0498 United Kingdom (Toll-Free): +44 800 358 1035 Access Code: 022503

 

Further call details will be available shortly on the Investor Relations section of our website www.kingspangroup.com. A recording of this conference call will be made available. For further information about the conference call please contact: ir@kingspan.com or +353 (0)42 969 8000.

 

 

Lorcan Dowd

Company Secretary

+ 353 (0)42 9698000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQEAPXXFDXDEFA
Date   Source Headline
24th Nov 201410:22 amRNSHolding(s) in Company
18th Nov 20144:49 pmRNSHolding(s) in Company
11th Nov 201412:48 pmRNSAcquisition
10th Nov 20147:00 amRNSInterim Management Statement
6th Nov 20149:35 amRNSHolding(s) in Company
3rd Nov 201411:15 amRNSTotal Voting Rights
3rd Nov 20147:00 amRNSAcquisition update
14th Oct 201410:11 amRNSHolding(s) in Company
2nd Oct 20145:09 pmRNSDirector/PDMR Shareholding
1st Oct 201411:00 amRNSTotal Voting Rights
29th Sep 20143:00 pmRNSHolding(s) in Company
12th Sep 201412:00 pmRNSDirector/PDMR Shareholding
8th Sep 20147:00 amRNSMain Securities Market Notice
2nd Sep 20145:01 pmRNSBlock Listing Application
1st Sep 201410:22 amRNSTotal Voting Rights
28th Aug 20145:59 pmRNSHolding(s) in Company
26th Aug 20147:00 amRNSHalf Yearly Report
18th Aug 20142:30 pmRNSHolding(s) in Company
18th Aug 201410:26 amRNSHolding(s) in Company
18th Aug 20147:00 amRNSAcquisition
30th Jul 20143:42 pmRNSHolding(s) in Company
29th Jul 20143:07 pmRNSHolding(s) in Company
3rd Jul 201412:39 pmRNSHolding(s) in Company
1st Jul 20142:50 pmRNSBlocklisting Interim Review
1st Jul 201410:45 amRNSTotal Voting Rights
23rd Jun 201410:48 amRNSDirector/PDMR Shareholding Replacement
19th Jun 20144:43 pmRNSDirector/PDMR Shareholding
19th Jun 201412:56 pmRNSDirector/PDMR Shareholding
19th Jun 201410:12 amRNSHolding(s) in Company
3rd Jun 20141:07 pmRNSDirector/PDMR Shareholding
3rd Jun 201410:36 amRNSTotal Voting Rights
22nd May 201412:22 pmRNSDirector/PDMR Shareholding
1st May 20143:32 pmRNSDirectorate Change
1st May 201410:39 amRNSAGM Results
1st May 20148:00 amRNSTotal Voting Rights
1st May 20147:00 amRNSInterim Management Statement
10th Apr 20144:39 pmRNSDirector/PDMR Shareholding
3rd Apr 201410:27 amRNSHolding(s) in Company
2nd Apr 20149:59 amRNSTotal Voting Rights
28th Mar 20146:30 pmRNSAnnual Financial Report
28th Mar 20147:01 amRNSSuccessful extension and re-pricing of EUR300m RCF
6th Mar 20144:49 pmRNSDirector/PDMR Shareholding
4th Mar 20144:06 pmRNSDirector/PDMR Shareholding
3rd Mar 201410:28 amRNSTotal Voting Rights
26th Feb 20145:27 pmRNSDirector/PDMR Shareholding
26th Feb 20143:48 pmRNSHolding(s) in Company
25th Feb 201412:52 pmRNSDirector/PDMR Shareholding
24th Feb 20147:00 amRNSFinal Results
24th Feb 20147:00 amRNSMain Securities Market Notice
21st Feb 20143:35 pmRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.